The standard use of known survival predictors for ovarian cancer in clinica
l practice are primarily based on disease stage. This does not permit a rea
l individualization of a patient's potential outcome. This study assessed t
he value of neural networks to refine the prediction of survival based only
on information gleaned at primary surgery. The possibility exists that suc
h methods map permit further elucidation of outcome and influence managemen
t.